CRM vs UNH: Which Is the Better Buy?
Side-by-side comparison of Salesforce, Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
Salesforce, Inc. · Technology
$182.14
+45.0% upside to fair value
Grade B
High Quality
VS
UnitedHealth Group Incorporated · Healthcare
$353.52
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
CRM trades at a lower forward P/E
(22.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRM |
UNH |
| Current Price |
$182.14 |
$353.52 |
| Fair Value Estimate |
$264.10 |
$512.60 |
| Upside to Fair Value |
+45.0%
|
+45.0%
|
| Market Cap |
$173.0B |
$320.9B |
| Forward P/E |
22.8x
|
26.7x
|
| EV / EBITDA |
14.4x
|
16.1x
|
| Price / Sales |
4.2x
|
0.7x
|
| Price / FCF |
12.0x
|
16.3x
|
| Revenue Growth YoY |
+12.1%
|
+2.0%
|
| Gross Margin |
77.7%
|
18.8%
|
| Operating Margin |
21.5%
|
4.2%
|
| Return on Equity |
12.4%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
8.33%
|
6.13%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Salesforce, Inc. is a leading enterprise software company specializing in cloud-based customer relationship management and enterprise applications. The company benefits from a durable competitive moat anchored by pioneering SaaS delivery, a large and growing customer base, and a diversified revenue mix with Service Cloud as the largest segment generating $9.05 billion in FY2025. Salesforce exhibi…
UnitedHealth Group Incorporated operates as a leading healthcare company with two main platforms: UnitedHealthcare, providing health benefits coverage, and Optum, offering information and technology services. The company benefits from a durable competitive moat due to its scale, integrated platforms, and broad market reach serving over 170 million consumers. Despite strong revenue growth of 12% y…
Accumulation Zones
| Metric |
CRM |
UNH |
| Zone Low |
$198.08 |
$384.45 |
| Zone High |
$224.49 |
$435.71 |
| In Buy Zone? |
Yes
|
Yes
|